REAL-TIME GLOBAL RESEARCH
EBOS Group Ltd (EBO.AX): Model Update
Research evidence excerpt
EBOS Group Ltd (EBO.AX): Model Update
12,610 11,593 12,720 13,321 14,028
Inventory 1,210 1,345 1,327 1,397 1,470 Animal Care 579 673 905 948 1,005
Net fixed & other tangibles 686 801 862 900 945 Revenue - total segments 13,189 12,267 13,625 14,269 15,033
Goodwill & intangibles 2,598 2,810 2,868 2,818 2,768
Financial & other assets 539 624 597 579 560 EBITDA (A$m) 2024 2025 2026E 2027E 2028E
Total assets 6,744 7,278 7,598 7,797 8,011 Healthcare 537 472 518 549 582
Accounts payable 2,213 2,441 2,511 2,643 2,782 Animal Care 104 123 140 155 166
Short-term debt 766 16 40 40 40 Corporate -36 -39 -43 -48 -53
Long-term debt 470 1,087 1,331 1,331 1,331 EBITDA - total segments 606 556 614 655 695
Provisions & other liab 877 1,011 1,005 1,004 1,003
Total liabilities 4,326 4,554 4,887 5,018 5,156 EBITDA Margin (%) 2024 2025 2026E 2027E 2028E
Shareholders' equity 2,451 2,740 2,758 2,823 2,896 Healthcare 4.3 4.1 4.1 4.1 4.2
Minority interests -33 -16 -47 -44 -41 Animal Care 18.0 18.2 15.4 16.3 16.5
Total equity 2,418 2,724 2,711 2,779 2,855 EBITDA margin - total segments 4.6 4.5 4.5 4.6 4.6
Net debt 1,019 918 1,081 1,010 938
Cashflow (A$m) 2024 2025 2026E 2027E 2028E
EBITDA 651 612 640 682 722
Working capital -61 98 -95 -26 -28
Net interest paid 2 -58 -15 0 0
Tax paid -13 -15 -7 0 0
Other -231 -219 -239 -246 -255
Operating cashflow 348 419 285 409 440
Capex -119 -146 -143 -95 -105
Net acq/disposals -246 -202 -84 0 0
Other -13 -21 0 0 0
Investing cashflow -378 -369 -227 -95 -105
Dividends paid -156 -137 -161 -180 -196
Financing cashflow 34 -85 53 -244 -263
Net change in cash 4 -35 111 71 72
Free cashflow to s/holders 229 273 142 315 335
The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.
Open report viewer